Evidence Based Medicine – questions about clinical endpoints Review article

Main Article Content

Marcin Grabowski

Abstract

Analysis of described clinical endpoints is crucial in interpretations of clinical trials results. The next issues of section “ABC of the Evidence Based Medicine (EBM)” presents basic information on types and combining clinical endpoints used in clinical trial. Arguments for and against some of them, and guidance on their application is provided.

Article Details

How to Cite
Grabowski , M. (2009). Evidence Based Medicine – questions about clinical endpoints. Medycyna Faktow (J EBM), 2(1(2), 66-69. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2684
Section
Articles

References

1. Grabowski M., Filipiak K.J.: Evidence Based Medice na przykładzie badań z lekami hipolipemizującymi – 44 pytania i odpowiedzi. Medical Education, Warszawa 2008: 1-81.
2. Freemantle N., Calvert M., Wood J., Eastaugh J., Griffin C.: Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 2003; 289(19): 2554-2559.
3. Lauer M.S., Topol E.J.: Clinical trials – multiple treatments, multiple endpoints, and multiple lessons. JAMA 2003; 289(19): 2575-2577.
4. Fox K., Garcia M.A., Ardissino D., Buszman P., Camici P.G., Crea F. et al.: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006; 27(11): 1341-1381.
5. McAlister F.A., Straus S.E., Sackett D.L., Altman D.G.: Analysis and reporting of factorial trials: a systematic review. JAMA 2003; 289(19): 2545-2553.